Inventor · disambiguated record
Jeffrey Claude Pelletier
Also filed as: PELLETIER JEFFREY C · PELLETIER JEFFREY CLAUDE
27 granted patents·10 pending applications·224 citations·filing 1988–2025
96Inventor score
Files withWYETH CORP13BIOHAVEN THERAPEUTICS LTD5RORER PHARMACEUTICAL CORP5UNIV COLUMBIA4BIOHAVEN PHARM HOLDING CO LTD3
Top patents by PatentIndex Score
37 records- 0192US11440893B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Sep 13, 2022·2 cites·5 claims
- 0290US10844026B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2020·Granted Nov 24, 2020·2 cites·7 claims
- 0387US6506901B2Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonistsWYETH CORP·Filed 2001·Granted Jan 14, 2003·22 cites·5 claims
- 0487US4920219ASubstituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agentsRORER PHARMACEUTICAL CORP·Filed 1988·Granted Apr 24, 1990·23 cites·7 claims
- 0587US4920227ABenzobicyclic carboxamide 5-HT3 antagonistsRORER PHARMACEUTICAL CORP·Filed 1988·Granted Apr 24, 1990·23 cites·8 claims
- 0686US4952562AAnti-thrombotic peptides and pseudopeptidesRORER PHARMACEUTICAL CORP·Filed 1989·Granted Aug 28, 1990·57 cites·12 claims
- 0785US6667303B1Aryl substituted 1,4-diazepanes and method of use thereofWYETH CORP·Filed 2002·Granted Dec 23, 2003·16 cites·54 claims
- 0885US4935511ABenzoxazine and benzoxazepine carboxamide 5-HT3 antagonistsRORER PHARMACEUTICAL CORP·Filed 1989·Granted Jun 19, 1990·20 cites·10 claims
- 0984US4933445AHeteroazabenzobicyclic carboxamide 5-HT3 antagonistsRORER PHARMACEUTICAL CORP·Filed 1988·Granted Jun 12, 1990·19 cites·7 claims
- 1083US7538113B24-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptorWYETH CORP·Filed 2006·Granted May 26, 2009·4 cites·17 claims
- 1182US12172974B2Prodrugs of riluzole and their method of useBIOHAVEN PHARM HOLDING CO LTD·Filed 2022·Granted Dec 24, 2024·0 cites·8 claims
- 1279US10428047B2MAP kinase modulators and uses thereofUNIV COLUMBIA·Filed 2017·Granted Oct 1, 2019·2 cites·11 claims
- 1378US12005046B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2021·Granted Jun 11, 2024·0 cites·8 claims
- 1478US9783525B2Map kinase modulators and uses thereofUNIV COLUMBIA·Filed 2015·Granted Oct 10, 2017·2 cites·17 claims
- 1576US11149020B2MAP kinase modulators and uses thereofUNIV COLUMBIA·Filed 2019·Granted Oct 19, 2021·1 cites·15 claims
- 1674US11566016B2MAP kinase modulators and uses thereofUNIV COLUMBIA·Filed 2021·Granted Jan 31, 2023·0 cites·5 claims
- 1771US7696210B2Gonadotropin releasing hormone receptor antagonistsWYETH CORP·Filed 2005·Granted Apr 13, 2010·2 cites·23 claims
- 1871US7582634B27-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptorWYETH CORP·Filed 2006·Granted Sep 1, 2009·1 cites·17 claims
- 1971US7534796B2Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptorWYETH CORP·Filed 2006·Granted May 19, 2009·1 cites·17 claims
- 2071US5063230ASubstituted saturated and unsaturated indole quinoline and benzazepine carboxamides and their use as pharmacological agentsRHONE POULENC RORER PHARMA·Filed 1990·Granted Nov 5, 1991·12 cites·2 claims
- 2168US12295942B2Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2021·Granted May 13, 2025·0 cites·5 claims
- 2268US2025332148A1Riluzole prodrugs and their useBIOHAVEN THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 2363US2021236470A1Prodrugs of riluzole and their method of useBIOHAVEN THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2452US2009048282A1Pyrimidine sulfonamide analogs and their use as agonists of the wnt-beta-catenin cellular messaging systemWYETH CORP·Filed 2008·Application pending·0 cites
- 2551US12030868B2Prodrugs of CGRP antagonistsPFIZER IRELAND PHARMACEUTICALS·Filed 2019·Granted Jul 9, 2024·0 cites·20 claims
- 2651US2008287452A1Heteroaryl/aryl pyrimidine analogs and their use as agonists of the wnt-beta-catenin cellular messaging systemWYETH CORP·Filed 2008·Application pending·0 cites
- 2750US2024067651A1Prodrugs of myeloperoxidase inhibitorsBIOHAVEN THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2850US2024018121A1Novel heteroaromatic compounds exhibiting antifungal activity and their method of useFOX CHASE CHEMCIAL DIVERSITY CENTER INC·Filed 2021·Application pending·0 cites
- 2946US6048853A1-arylphthalazine antagonists of excitatory amino acid receptorsBEARSDEN BIO INC·Filed 1996·Granted Apr 11, 2000·6 cites·11 claims
- 3046US2009069319A1Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging systemWYETH CORP·Filed 2008·Application pending·0 cites
- 3146US2009054392A1Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging systemWYETH CORP·Filed 2008·Application pending·0 cites
- 3245US7531542B2Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptorWYETH CORP·Filed 2006·Granted May 12, 2009·0 cites·30 claims
- 3345US5716956ADihydrophthalazine antagonists of excitatory amino acid receptorsBEARSDEN BEARSDEN BIO INC·Filed 1996·Granted Feb 10, 1998·9 cites·9 claims
- 3444US2006111355A1Gonadotropin releasing hormone receptor antagonistsWYETH CORP·Filed 2005·Application pending·0 cites
- 3544US2002065309A1Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonistsFiled 2001·Application pending·0 cites
- 3643US7582636B2Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptorWYETH CORP·Filed 2006·Granted Sep 1, 2009·0 cites·26 claims
- 3739US10780084B2Antibody-recruiting molecules for the treatment of cancerUNIV YALE·Filed 2017·Granted Sep 22, 2020·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →